CMO Moves: Regulatory Catalysts for Drug Manufacturing-November
Pharmaceutical Technology
NOVEMBER 30, 2022
Each month, Pharmaceutical Technology takes a look at recent decisions taken by regulatory and reimbursement agencies and identifies the key manufacturing players that can be impacted by them. Following similar decisions by the American and European regulators, Swissmedic approved Pfizer/BioNTech’s bivalent Comirnaty booster.
Let's personalize your content